Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

Tiller Murder Unlikely To Stall Abortion Debate In Kansas
Antiabortion-rights legislators in Kansas plan to push for harsher restrictions on abortion when the next legislative session begins in January 2010, despite increased tensions following the murder of abortion provider George Tiller, the AP/Indianapolis Star reports.According to state House Judiciary Committee Chair Lance Kinzer (R), the debate over abortion rights should continue in the state because some laws aimed at restricting abortion access are not being enforced properly. This year, Kinzer pushed legislation (S.B. 218) to strengthen the state"s restrictions on abortions performed later in pregnancy, but the bill was vetoed by former Gov. Kathleen Sebelius (D). Gov. Mark Parkinson (D) has said his views are "very similar" to those of Sebelius on abortion rights. On Monday, he called on advocates on both sides of the issue to tone down their rhetoric. Parkinson also has said that Kansas should aim to reduce unplanned pregnancies.State Rep. Tom Sawyer (D), who supports abortion rights, said he would like to see legislators take one year off of debating the issue, adding that he thinks this is unlikely. He said, "It"d be nice to have one session where we didn"t have to debate it," adding, "People who are adamant, who keep bringing up these issues, are going to keep bringing them up. I don"t think [Tiller"s murder] is going to slow them down."However, state House Speaker Mike O"Neal (R) said tensions over abortion rights "will calm down a great deal" in the coming months. He added, "All those issues are still there. As long as the parties on both sides behave themselves and not let the rhetoric get out [of] hand, I think we can stay focused on the issues." State Sen. Tim Huelskamp (R) said that abortion-rights opponents likely will focus in the short term on the Board of Healing Arts, which licenses and regulates physicians, and the courts. A criminal case against a Planned Parenthood clinic in Johnson County, Kan., is pending (Hanna, AP/Indianapolis Star, 6/5).
generic viagra online
American Pharmacists Association Seeks Nominations For Practitioner Awards And Honors
The American Pharmacists Association (APhA), the national professional society of pharmacists, announces that nominations are now being accepted for the Association"s practitioner awards and honors. Presentation of these awards is scheduled for the APhA Annual Meeting and Exposition in Washington, DC, March 12-15, 2010. Nominations must be received at APhA headquarters by September 15, 2009. APhA"s awards recognition program is American pharmacy"s most comprehensive recognition program. Purchase zoloft to treat depression.
News of the day
Well Before Symptoms Appear A Fatal Brain Disease Is At Work
University of Florida scientists have discovered why a paralyzing brain disorder speeds along more rapidly in some patients than others - a finding that may finally give researchers an entry point toward an effective treatment for amyotrophic lateral sclerosis, often referred to as ALS or Lou Gehrig"s disease.
Nutrition

Early Switch From Cyclosporine To Sirolimus After Renal Transplantation Produces Sustained Improvement In Renal Function

BOSTON - Favorable 12-month outcomes are maintained through 30 months of follow-up when renal transplant patients are converted from a cyclosporine (CsA)-based regimen to a sirolimus (SRL)-based regimen three months post-transplant, according to results of the CONCEPT study announced here at the American Transplant Congress (ATC) 2009. Yvon Lebranchu, MD, from the University FranÃýois Rabelais in Tours, France, reported 30-month results in patients who were initially treated with mycophenolate mofetil (MMF) plus cyclosporine (CsA) and then randomized three months later to continue this regimen, or CsA therapy was stopped and replaced by SRL. The trial included 192 first-time renal allograft recipients at 16 centers throughout France. "Long term use of CsA may contribute to the development of chronic allograft nephropathy," Dr. Lebranchu pointed out. "While earlier trials have demonstrated a positive impact of de novo SRL on renal function at one year post transplantation, adverse effects have limited the use of this approach." An analysis at 12 months in 181 patients found that glomerular filtration rate (GFR), as estimated by the simplified MDRD formula, was significantly better in the SRL group (61.9 mL/min versus 53.8 mL/min, p=0.0002). Improvement in renal function occurred without a significant increase in acute rejection. Thirty-month results in 152 patients in the intent-to-treat population showed an MDRD GFR of 58.3 mL/min and 52.6 mL/min in the two groups, respectively, p=0.027. This difference was more pronounced in patients on treatment: 64.4 mL/min and 53.8 mL/min in the two groups, respectively. Graft loss and patient survival were similar in the two treatment groups. One patient in the SRL/MMF group had developed a malignancy versus six patients in the CsA group. "Long-term maintenance of renal function is a challenge in renal transplant recipients, and the use of CNIs is associated with chronic long-term graft dysfunction," Dr. Lebranchu said. "The identification of strategies of CNI avoidance or elimination is extremely important." Sandi See Tai, MD, Director, Global Medical Affairs, Transplantation, Wyeth Pharmaceuticals, said that the data are encouraging "because they indicate better long-term outcomes for kidney transplant patients." Wyeth Pharmaceuticals markets sirolimus under the trade name RAPAMUNE®. "Overall, the interim results of CONCEPT show that a sirolimus-based regimen may provide lasting benefits in renal transplant patients," Dr. Lebranchu added. Written by Jill Stein Jill Stein is a Paris-based freelance medical writer. jillstein03(at)gmail.com Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009